For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
Global Medical REIT Inc (NYSE: GMRE) closed the day trading at $6.27 down -5.14% from the previous closing price of $6.61. In other words, the price has decreased by -$5.14 from its previous closing price. On the day, 0.92 million shares were traded.
Ratios:
For a better understanding of GMRE, let’s look at its different ratios. In the meantime, Its Debt-to-Equity ratio is 1.34 whereas as Long-Term Debt/Eq ratio is at 1.31.
On October 18, 2024, Berenberg started tracking the stock assigning a Buy rating and target price of $11.75.
On September 19, 2024, Alliance Global Partners started tracking the stock assigning a Buy rating and target price of $12.Alliance Global Partners initiated its Buy rating on September 19, 2024, with a $12 target price.
Valuation Measures:
As of this moment, Global’s Price-to-Earnings (P/E) ratio for their current fiscal year is 200.32, and their Forward P/E ratio for the next fiscal year is 125.40. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.85. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.95 while its Price-to-Book (P/B) ratio in mrq is 0.95.
Stock Price History:
Over the past 52 weeks, GMRE has reached a high of $10.35, while it has fallen to a 52-week low of $6.58. The 50-Day Moving Average of the stock is -18.98%, while the 200-Day Moving Average is calculated to be -26.32%.
Shares Statistics:
A total of 66.88M shares are outstanding, with a floating share count of 63.10M. Insiders hold about 5.65% of the company’s shares, while institutions hold 68.35% stake in the company.
Earnings Estimates
A comprehensive evaluation of Global Medical REIT Inc (GMRE) is underway, with the input of 1.0 analysts contributing to its current rating.The consensus estimate for the next quarter is $0.01, with high estimates of $0.01 and low estimates of $0.01.
Analysts are recommending an EPS of between $0.83 and $0.83 for the fiscal current year, implying an average EPS of $0.83. EPS for the following year is $0.49, with 2.0 analysts recommending between $0.87 and $0.11.
Revenue Estimates
5 analysts predict $35.57M in revenue for the current quarter. It ranges from a high estimate of $36.16M to a low estimate of $34.66M. As of the current estimate, Global Medical REIT Inc’s year-ago sales were $34.24MFor the next quarter, 5 analysts are estimating revenue of $36.01M. There is a high estimate of $36.56M for the next quarter, whereas the lowest estimate is $35.12M.
A total of 6 analysts have provided revenue estimates for GMRE’s current fiscal year. The highest revenue estimate was $144.54M, while the lowest revenue estimate was $139.66M, resulting in an average revenue estimate of $142.9M. In the same quarter a year ago, actual revenue was $138.78MBased on 5 analysts’ estimates, the company’s revenue will be $148.93M in the next fiscal year. The high estimate is $156.02M and the low estimate is $144.44M.
